Anne Schmechtig

932 total citations
21 papers, 681 citations indexed

About

Anne Schmechtig is a scholar working on Cognitive Neuroscience, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Anne Schmechtig has authored 21 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cognitive Neuroscience, 10 papers in Psychiatry and Mental health and 6 papers in Molecular Biology. Recurrent topics in Anne Schmechtig's work include Schizophrenia research and treatment (8 papers), Functional Brain Connectivity Studies (7 papers) and Receptor Mechanisms and Signaling (4 papers). Anne Schmechtig is often cited by papers focused on Schizophrenia research and treatment (8 papers), Functional Brain Connectivity Studies (7 papers) and Receptor Mechanisms and Signaling (4 papers). Anne Schmechtig collaborates with scholars based in United Kingdom, Germany and Switzerland. Anne Schmechtig's co-authors include Ulrich Ettinger, Veena Kumari, Steven Williams, David Collier, Boris B. Quednow, Michael Wagner, Marcus S. Smith, Matthew J. Kempton, Nadine Petrovsky and Rainald Mößner and has published in prestigious journals such as The Lancet, Journal of Neuroscience and NeuroImage.

In The Last Decade

Anne Schmechtig

21 papers receiving 677 citations

Peers

Anne Schmechtig
June Kang South Korea
Joanna Szczepanik United States
C. Born Germany
Jaya Padmanabhan United States
Anne Schmechtig
Citations per year, relative to Anne Schmechtig Anne Schmechtig (= 1×) peers Masahito Nakataki

Countries citing papers authored by Anne Schmechtig

Since Specialization
Citations

This map shows the geographic impact of Anne Schmechtig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Schmechtig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Schmechtig more than expected).

Fields of papers citing papers by Anne Schmechtig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Schmechtig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Schmechtig. The network helps show where Anne Schmechtig may publish in the future.

Co-authorship network of co-authors of Anne Schmechtig

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Schmechtig. A scholar is included among the top collaborators of Anne Schmechtig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Schmechtig. Anne Schmechtig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mehta, Mitul A., Anne Schmechtig, Juliet McColm, et al.. (2018). Group II metabotropic glutamate receptor agonist prodrugs LY2979165 and LY2140023 attenuate the functional imaging response to ketamine in healthy subjects. Psychopharmacology. 235(7). 1875–1886. 31 indexed citations
2.
Koychev, Ivan, Daniel Joyce, Emma Barkus, et al.. (2016). Cognitive and oculomotor performance in subjects with low and high schizotypy: implications for translational drug development studies. Translational Psychiatry. 6(5). e811–e811. 12 indexed citations
3.
Kumari, Veena, et al.. (2016). The mindful eye: Smooth pursuit and saccadic eye movements in meditators and non-meditators. Consciousness and Cognition. 48. 66–75. 16 indexed citations
4.
Kumari, Veena, Ulrich Ettinger, Anantha P. Anilkumar, et al.. (2015). Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study. Psychopharmacology. 232(17). 3135–3147. 11 indexed citations
5.
Schmechtig, Anne, Jane Lees, Adam M. Perkins, et al.. (2013). The effects of ketamine and risperidone on eye movement control in healthy volunteers. Translational Psychiatry. 3(12). e334–e334. 19 indexed citations
6.
Perkins, Adam M., Ulrich Ettinger, Kristin Weaver, et al.. (2013). Advancing the defensive explanation for anxiety disorders: lorazepam effects on human defense are systematically modulated by personality and threat-type. Translational Psychiatry. 3(4). e246–e246. 23 indexed citations
7.
Schmechtig, Anne, Jane Lees, Kevin J. Craig, et al.. (2013). Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy. Psychopharmacology. 227(2). 331–345. 27 indexed citations
8.
Koychev, Ivan, Katrina McMullen, Jane Lees, et al.. (2013). Differential effect of amisulpride on cognition in schizotypy: validation of models for the early identification of cognitive enhancing agents. The Lancet. 381. S59–S59. 3 indexed citations
9.
Völter, Christoph J., Michael Riedel, Nicola Wöstmann, et al.. (2012). Sensorimotor gating and D2 receptor signalling: evidence from a molecular genetic approach. The International Journal of Neuropsychopharmacology. 15(10). 1427–1440. 14 indexed citations
10.
Owens, Sheena, Marco Picchioni, Ulrich Ettinger, et al.. (2012). Prefrontal deviations in function but not volume are putative endophenotypes for schizophrenia. Brain. 135(7). 2231–2244. 28 indexed citations
11.
Koychev, Ivan, Katrina McMullen, Jane Lees, et al.. (2011). A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: A three-center double-blind placebo-controlled study. European Neuropsychopharmacology. 22(7). 469–481. 34 indexed citations
12.
Quednow, Boris B., Ulrich Ettinger, Rainald Mößner, et al.. (2011). The Schizophrenia Risk Allele C of theTCF4rs9960767 Polymorphism Disrupts Sensorimotor Gating in Schizophrenia Spectrum and Healthy Volunteers. Journal of Neuroscience. 31(18). 6684–6691. 60 indexed citations
13.
Schmechtig, Anne, Jane Lees, G. D. Dawson, et al.. (2011). Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy. Pharmacopsychiatry. 44(6). 1 indexed citations
14.
Petrovsky, Nadine, Boris B. Quednow, Ulrich Ettinger, et al.. (2010). Sensorimotor Gating is Associated with CHRNA3 Polymorphisms in Schizophrenia and Healthy Volunteers. Neuropsychopharmacology. 35(7). 1429–1439. 61 indexed citations
15.
Ettinger, Ulrich, Anne Schmechtig, Timothea Toulopoulou, et al.. (2010). Prefrontal and Striatal Volumes in Monozygotic Twins Concordant and Discordant for Schizophrenia. Schizophrenia Bulletin. 38(1). 192–203. 33 indexed citations
16.
Schmechtig, Anne, Evangelos Vassos, Veena Kumari, et al.. (2010). Association of Neuregulin 1 rs3924999 genotype with antisaccades and smooth pursuit eye movements. Genes Brain & Behavior. 9(6). 621–627. 21 indexed citations
17.
Crawford, Trevor J., Jordan P. Hamm, Anne Schmechtig, et al.. (2010). The perception of real and illusory motion in schizophrenia. Neuropsychologia. 48(10). 3121–3127. 29 indexed citations
18.
Petrovsky, Nadine, Anne Schmechtig, Rachel Flomen, et al.. (2009). CHRFAM7A copy number and 2-bp deletion polymorphisms and antisaccade performance. The International Journal of Neuropsychopharmacology. 12(2). 267–267. 9 indexed citations
19.
Quednow, Boris B., Anne Schmechtig, Ulrich Ettinger, et al.. (2009). Sensorimotor Gating Depends on Polymorphisms of the Serotonin-2A Receptor and Catechol-O-Methyltransferase, but Not on Neuregulin-1 Arg38Gln Genotype: A Replication Study. Biological Psychiatry. 66(6). 614–620. 61 indexed citations
20.
Kempton, Matthew J., Ulrich Ettinger, Anne Schmechtig, et al.. (2007). Effects of acute dehydration on brain morphology in healthy humans. Human Brain Mapping. 30(1). 291–298. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026